BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Diagnosis
17 results:

  • 1. [Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation].
    Ma Y; Wang YH; Huang S; Zou ZG; Hu L; Guo LC
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1230-1236. PubMed ID: 38058039
    [No Abstract]    [Full Text] [Related]  

  • 2. Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis.
    Diez-Calzadilla NA; Noguera Salvá R; Soriano Sarrió P; Martínez-Jabaloyas JM
    Cancer Treat Res Commun; 2021; 27():100374. PubMed ID: 33932757
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Network-based metabolic characterization of renal cell carcinoma.
    Pandey N; Lanke V; Vinod PK
    Sci Rep; 2020 Apr; 10(1):5955. PubMed ID: 32249812
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma.
    Ambrosetti D; Dufies M; Dadone B; Durand M; Borchiellini D; Amiel J; Pouyssegur J; Rioux-Leclercq N; Pages G; Burel-Vandenbos F; Mazure NM
    PLoS One; 2018; 13(2):e0193477. PubMed ID: 29481555
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic significance of hypoxia inducible factor-1α expression in patients with clear cell renal cell carcinoma.
    Wu S; Jiang F; Wu H; Wang Y; Xu R; Cao J; Lu Q; Zhu X; Zhong Z; Zhao X
    Mol Med Rep; 2018 Mar; 17(3):4846-4852. PubMed ID: 29328439
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.
    Go H; Kang MJ; Kim PJ; Lee JL; Park JY; Park JM; Ro JY; Cho YM
    Pathol Oncol Res; 2019 Jan; 25(1):51-58. PubMed ID: 28963640
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LncRNA HOTAIR regulates HIF-1α/AXL signaling through inhibition of miR-217 in renal cell carcinoma.
    Hong Q; Li O; Zheng W; Xiao WZ; Zhang L; Wu D; Cai GY; He JC; Chen XM
    Cell Death Dis; 2017 May; 8(5):e2772. PubMed ID: 28492542
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Implication of VHL, ERK5, and hif-1alpha in clear cell renal cell carcinoma: Molecular basis.
    Serrano-Oviedo L; Giménez-Bachs JM; Nam-Cha SY; Cimas FJ; García-Cano J; Sánchez-Prieto R; Salinas-Sánchez AS
    Urol Oncol; 2017 Mar; 35(3):114.e15-114.e22. PubMed ID: 27836247
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hormone signaling pathways as treatment targets in renal cell cancer (Review).
    Czarnecka AM; Niedzwiedzka M; Porta C; Szczylik C
    Int J Oncol; 2016 Jun; 48(6):2221-35. PubMed ID: 27035677
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Correlation between BOLD-MRI and HIF expression level in renal carcinoma.
    Li D; Wang X; Wang S; Cheng J
    Int J Clin Exp Pathol; 2015; 8(10):13759-63. PubMed ID: 26722605
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Clinicopathologic features of clear cell papillary renal cell carcinoma].
    Rao Q; Shen Q; Shi S; Xia Q; Lu Z; Yu B; Zhang R; He Y; Wang X; Ma H; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Nov; 43(11):728-31. PubMed ID: 25582249
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases.
    Berghoff AS; Ilhan-Mutlu A; Dinhof C; Magerle M; Hackl M; Widhalm G; Hainfellner JA; Dieckmann K; Pichler J; Hutterer M; Melchardt T; Bartsch R; Zielinski CC; Birner P; Preusser M
    Neuropathol Appl Neurobiol; 2015 Feb; 41(2):e41-55. PubMed ID: 25256708
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Expression of VEGF-A, HIF-1 A, CD34 and Ki67 in clear cell renal cell carcinomas and their relationship with conventional prognostic markers.
    Bürgesser MV; Riva V; Ojeda SM; Muñoz Morales D; Calafat P; Diller A
    Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(1):7-15. PubMed ID: 25036445
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
    Tostain J; Li G; Gentil-Perret A; Gigante M
    Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hypoxia inducible factor-1alpha correlates with vascular endothelial growth factor A and C indicating worse prognosis in clear cell renal cell carcinoma.
    Dorević G; Matusan-Ilijas K; Babarović E; Hadzisejdić I; Grahovac M; Grahovac B; Jonjić N
    J Exp Clin Cancer Res; 2009 Mar; 28(1):40. PubMed ID: 19302703
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract.
    Ke HL; Wei YC; Yang SF; Li CC; Wu DC; Huang CH; Wu WJ
    Int J Urol; 2008 Mar; 15(3):200-5. PubMed ID: 18304212
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Lipid-rich variant of pancreatic endocrine neoplasms.
    Singh R; Basturk O; Klimstra DS; Zamboni G; Chetty R; Hussain S; La Rosa S; Yilmaz A; Capelli P; Capella C; Cheng JD; Adsay NV
    Am J Surg Pathol; 2006 Feb; 30(2):194-200. PubMed ID: 16434893
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.